Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis
Multiple Sclerosis Journal · 2026
DOI: 10.1177/13524585251407976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2026. Verfasst von Luca Bollo und 27 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, B…. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Multiple Sclerosis, Chronic Progressive, Brain, Spinal Cord. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Optical coherence tomography (OCT) enables in vivo assessment of retinal layers and is an emerging biomarker of neurodegeneration in multiple sclerosis (MS). In relapsing MS, peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness predict disease progression, but their role in primary progressive multiple sclerosis (PPMS) is unclear.
Objective
To determine whether pRNFL and GCIPL predict disability progression and retinal, brain, and spinal cord atrophy (SCA) in PPMS.
Methods
Retrospective longitudinal study of 69 PPMS patients with clinical, OCT, and magnetic resonance imaging (MRI) data. Patients stratified by pRNFL and GCIPL thickness tertiles (lower vs intermediate-upper). Annual thinning rates for pRNFL and GCIPL (aLpRNFL and aLGCIPL) estimated via linear regression. MRI assessed baseline and follow-up brain volumes, spinal cord area, and percentage of brain volume change (PBVC). Analyses included regression models, Kaplan–Meier, and Cox survival regression. Results: pRNFL ⩽ 87 μm was associated with higher follow-up Expanded Disability Status Scale (EDSS) (6.0 (interquartile range (IQR) = 4.5–6.5) vs 4.0 (IQR = 3.0–6.0), p = 0.013). Risk of confirmed disability progression (CDP) increased 3.4-fold (95% confidence interval (CI) = 1.03–11.30, p = 0.044) over 2 years (IQR = 1.0–3.0), with median time to CDP of 1.84 vs 3.67 years ( p = 0.027). Longitudinally, pRNFL ⩽87 μm showed faster retinal thinning (aLpRNFL = −1.66 vs −0.31 µm/year, p < 0.001), greater whole-brain atrophy (PBVC = −1.20%, p = 0.037), and greater SCA ( B = 0.333, p = 0.008).
Conclusion
In PPMS, pRNFL predicts disability progression and greater retinal, brain, and SCA, supporting its role as a surrogate marker of neurodegeneration in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
- Multiple Sclerosis Center of Catalonia (Cemcat) and Department of Neurology Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; Universitat de Vic-Universitat Central de Catalunya (…
- Neurology department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Multiple Sclerosis Center of Catalonia (Cemcat), Barcelona, Spain.
ORCID-Profile: Luca Bollo, Deborah Pareto, Paula Tagliani, Àlvaro Cobo-Calvo, Carmen Tur, Georgina Arrambide, Neus Mongay-Ochoa, Agustin Pappolla, Luciana Midaglia, Breogan Rodriguez-Acevedo, Jordi Rio, Andreu Vilaseca, Ana Zabalza, Manuel Comabella, Mar Tintoré, Jaume Sastre-Garriga, Àlex Rovira, Angela Vidal-Jordana
Zitieren
APA
Bollo, L., Pareto, D., Tagliani, P., Sceppacuercia, S., Alberich, M., Cabello, S., Carbonell, P., Villacieros-Álvarez, J., Cobo-Calvo, À., Tur, C., Arrambide, G., Carvajal, R., Castilló, J., Galan, I., Mongay-Ochoa, N., Pappolla, A., Midaglia, L., Rodriguez-Acevedo, B., Rio, J., …, & Vidal-Jordana, A. (2026). Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585251407976
Vancouver
Bollo L, Pareto D, Tagliani P, Sceppacuercia S, Alberich M, Cabello S, et al. Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis. Multiple Sclerosis Journal. 2026. doi:10.1177/13524585251407976
BibTeX
@article{Bollo2026,
author = {Bollo, Luca and Pareto, Deborah and Tagliani, Paula and Sceppacuercia, Sofia and Alberich, Manel and Cabello, Sergio and Carbonell, Pere and Villacieros-Álvarez, Javier and Cobo-Calvo, Àlvaro and Tur, Carmen and Arrambide, Georgina and Carvajal, Renè and Castilló, Joaquín and Galan, Ingrid and Mongay-Ochoa, Neus and Pappolla, Agustin and Midaglia, Luciana and Rodriguez-Acevedo, Breogan and Rio, Jordi and Vilaseca, Andreu and Zabalza, Ana and Comabella, Manuel and Auger, Cristina and Tintoré, Mar and Sastre-Garriga, Jaume and Rovira, Àlex and Montalban, Xavier and Vidal-Jordana, Angela},
title = {Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis},
journal = {Multiple Sclerosis Journal},
year = {2026},
doi = {10.1177/13524585251407976}
}
EUVIMED